Capricor Therapeutics (CAPR) Q3 2025 Earnings

11AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.57
-0.43
-0.3
-0.16

Details

Expected EPS
-0.476
Actual EPS
-0.57
Surprise EPS
-0.09
Surprise Percent
+19.75%

Description

Capricor Therapeutics (CAPR) has reported earnings of -0.57 per share for Q3 2025.

0 Comments

Share your thoughts